Company details

HEADCOUNT

1-24

ORG TYPE

Startup

SECTOR

Finance

WEBSITE

http://www.oxular.com

About the company

Oxular is a UK biotech that developed long-acting drug and delivery approaches for retinal diseases, with a focus on suprachoroidal delivery and sustained-release formulations. Oxular’s public materials position the lead work around reducing treatment burden for conditions like diabetic macular edema. Oxular was acquired by Regeneron in January 2025, and Oxular’s public-facing footprint now reads more like a pipeline and technology microsite than an active standalone employer.

Locations and presence

Oxular’s public company profile lists Oxford, England as headquarters, with a site presence associated with Oxford Science Park. The Oxular website also lists a London address for the company entity and a UK contact number.

Palpable Score

26.6

/ 100

Oxular does not currently present as a standalone hiring destination for graduates, largely because the company was acquired and there is no active careers funnel to assess. The few publicly visible hiring artifacts are senior-leaning and third-party, which limits confidence on fairness, support, and early-career outcomes.

Pillar 1: Early-career access

Score

2.5

/ 20

The company does not publish a jobs page, internships, or working-student roles on the Oxular website navigation, which removes the most common early-career entry points.
Oxular’s LinkedIn profile frames Oxular as acquired in January 2025, which typically means fewer standalone openings and less recurring junior hiring.
The company has only sporadic third-party role advertising visible publicly, and the roles surfaced are not pitched at 0–3 years

Pillar 2: Hiring fairness and transparency

Score

7.5

/ 20

The company does not publish an interview process, hiring stages, or response-time expectations on the Oxular website.
Oxular has at least one detailed third-party job write-up (Finance Business Partner) that lays out responsibilities and benefits, which helps candidates understand scope before applying.
The company does not show salary ranges in the visible Oxular-specific recruiting material, which reduces transparency for candidates weighing offers.

Pillar 3: Learning and support

Score

5.0

/ 20

The company’s public-facing pages focus on pipeline and technology rather than how teams onboard, learn, or get coached.
Oxular is described in at least one role ad as a small, multidisciplinary team, which can mean high exposure to senior decision-makers, but the job copy does not spell out mentorship mechanics.
The company does not publish practical support signals like a buddy system, ramp plan, or feedback cadence in any candidate-facing place that’s easy to find.

Pillar 4: Pay fairness and stability

Score

8.8

/ 20

The company has at least one published benefits snapshot for an Oxular role, including pension contributions, private medical insurance, and 25 days’ holiday plus bank holidays.
Oxular lists variable pay elements (a discretionary bonus reference) and calls pay “competitive,” but the public material does not quantify base salary.
The company’s acquisition context makes pay and stability harder to judge for new hires because ongoing standalone hiring appears limited.

Pillar 5: Early-career outcomes

Score

2.8

/ 20

The company has almost no public early-career progression proof (no intern conversion rates, promotion timelines, or junior career paths).
Oxular has a minimal employer-review footprint, including a Glassdoor profile that prompts visitors to be the first to add a review, which limits outcomes evidence.
The company’s post-acquisition situation has been publicly described as not carrying employees into Regeneron long-term, which complicates retention and continuity signals for early-career candidates.